FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for cell-mediated gene therapy for ischemic stroke. Therapeutic effective dose of genetic material consisting of a gene for vascular endothelial growth factor VEGF, a gene for glial neurotrophic factor GDNF and a gene for neuronal adhesion molecule NCAM, is directly administered by intrathecal injection within 4 hours after the onset of ischemic cerebral stroke.
EFFECT: invention provides a medicinal product for preventing and controlling the death of neurons in ischemic cerebral stroke.
1 cl, 2 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTIVE GENE THERAPY FOR SUPPRESSING NEURON DEATH IN ISCHEMIC BRAIN STROKE | 2020 |
|
RU2748940C2 |
METHOD OF PERSONALIZED GENE THERAPY IN CASE THERE IS THREAT OF ISCHEMIC CEREBRAL STROKE | 2023 |
|
RU2808256C1 |
METHOD FOR TREATING TRAUMATIC SPINAL CORD INJURY | 2021 |
|
RU2758760C1 |
METHOD FOR PREPARING A CELL-MEDIATED GENE THERAPY AGENT AND A CELL-MEDIATED GENE THERAPY AGENT | 2019 |
|
RU2716013C2 |
PHARMACEUTICAL COMPOSITION AND METHOD FOR USING THE SAME FOR THE TREATMENT OF BRAIN AND SPINAL CORD INJURIES | 2022 |
|
RU2784233C1 |
METHOD FOR STIMULATING SPINAL CORD REGENERATION WITH GENETICALLY MODIFIED HUMAN UMBILICAL CORD BLOOD CELLS | 2013 |
|
RU2521225C2 |
METHOD FOR STIMULATING NEUROGENERATION BY GENETIC MAKE-UPS | 2011 |
|
RU2459630C1 |
NOOTROPIC COMPOSITION BASED ON POLYPEPTIDE COMPLEXES ISOLATED FROM NEURONAL PROGENITOR CELLS UNDER HEAT SHOCK AND METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2752906C2 |
METHOD FOR PRODUCING PREPARATION OF GENETICALLY MODIFIED CELLS | 2009 |
|
RU2431669C2 |
NOOTROPIC COMPOSITION BASED ON POLYPEPTIDE COMPLEXES RECOVERED FROM NEURONAL PROGENITOR CELLS UNDER HYPOXIC CONDITIONS, AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2732600C1 |
Authors
Dates
2019-01-10—Published
2017-12-01—Filed